-
Top Narrow Based Indexes For January 24 (CLDA, LDK, GXDX)
Monday, January 24, 2011 - 12:09pm | 218By 11:05 am, the Dow Jones Industrial Average was up 57.48 points, or 0.48%, to 11,929.32, while the broader Standard & Poor's 500 index had gained 3.50 points, or 0.27%. The NASDAQ composite index rose 10.45 points, or 0.39%. Some of the narrow based indexes driving the markets are Genetic...
-
Earnings Preview: Varian Medical - Analyst Blog
Monday, January 24, 2011 - 12:01pm | 755Varian Medical Systems (VAR) is slated to report first quarter fiscal 2011 (ending December 31) results on January 26. The company expects earnings per share in the range of 71 cents to 74 cents for the quarter. The current Zacks Consensus Estimate for the first quarter is 73 cents, representing...
-
Benzinga's Volume Movers (GXDX, CLDA, HUGH, LPHI)
Monday, January 24, 2011 - 11:48am | 182Genoptix Inc (NASDAQ: GXDX) shares moved up 25.76% to $24.85 at 10:46 am. The volume of GXDX shares traded was 12456% higher than normal. Novartis AG (NYSE: NVS) announced its plans to buy GXDX for $470 million, or $25 per share, representing a 39% premium over GXDX's share value on December 13,...
-
Earnings Preview: Varian Medical - Analyst Blog
Monday, January 24, 2011 - 11:45am | 755Varian Medical Systems (VAR) is slated to report first quarter fiscal 2011 (ending December 31) results on January 26. The company expects earnings per share in the range of 71 cents to 74 cents for the quarter. The current Zacks Consensus Estimate for the first quarter is 73 cents, representing...
-
Options Brief: Clinical Data, Inc. (CLDA)
Monday, January 24, 2011 - 11:41am | 77Shares of Clinical Data, Inc. (NASDAQ: CLDA) are higher on the session by 57.49%, trading at $23.67. Overall call volume is now running at 9.12x the daily average, with 25% of all calls traded being purchases on the offer. 25,695 contracts have traded on the session so far. Clinical Data, Inc. is...
-
NASDAQ Stocks Hitting 52-Week Highs (BAGL, CLDA, OCCF, SILC)
Monday, January 24, 2011 - 11:39am | 146Einstein Noah Restaurant Group Inc (NASDAQ: BAGL) shares gained 3.63% to create a new 52-week high of $15.42. Stifel Nicolaus analyst Matthew Van Vliet upgraded BAGL from "hold" to "buy." Clinical Data Inc (NASDAQ: CLDA) shares jumped 59.55% to touch a new 52-week high of $23.98. The Food and Drug...
-
Wells Fargo Downgrades STJ To Market Perform From Outperform
Monday, January 24, 2011 - 11:25am | 110Wells Fargo is downgrading St. Jude Medical, Inc. (NYSE: STJ) to Market Perform from Outperform “because we expect the US ICD market to suffer from a near-term reduction in implants of about 10% due to the announcement by the Heart Rhythm Society (HRS) on January 20th that it is advising the...
-
Company News for January 24, 2011 - Corporate Summary
Monday, January 24, 2011 - 11:07am | 409• SunTrust Banks Inc (NYSE:STI) increased 5.9% after the bank posted good earnings number resulting from lower loan-loss provisions, beating analysts' estimates • Share prices of BB&T Corp (NYSE:BBT) rose 4.8% after its revenue increased by 12% • Share prices of Drug maker Hospira (NYSE:HSP),...
-
Morning Market Movers (CLDA, OCCF, SSCC, GXDX)
Monday, January 24, 2011 - 10:54am | 167Clinical Data Inc (NASDAQ: CLDA) climbed 55.22% to $23.33 at 9:50 am. The Food and Drug Administration (FDA) approved the CLDA's depression drug Viibryd. Optical Cable Corporation (NASDAQ: OCCF) shares surged 35.14% to $5.00. OCCF reported 31.1% y/y surge in its Q4 net sales. Smurfit-Stone...
-
Company News for January 24, 2011 - Corporate Summary
Monday, January 24, 2011 - 10:15am | 409• SunTrust Banks Inc (NYSE:STI) increased 5.9% after the bank posted good earnings number resulting from lower loan-loss provisions, beating analysts' estimates • Share prices of BB&T Corp (NYSE:BBT) rose 4.8% after its revenue increased by 12% • Share prices of Drug maker Hospira (NYSE:HSP),...
-
ResMed Earnings To Be Reported On January 28
Monday, January 24, 2011 - 10:01am | 113JP Morgan has published a research report on ResMed, Inc. (NYSE: RMD) in preview of the company's earnings report scheduled for January 28, 2011 at 8:00 a.m. In the report, JP Morgan writes "We expect RMD's 2Q11 is unlikely to provide any improvement in underlying US market flow generator volume...
-
Benzinga's Top Upgrades (CAB, KCI, EQIX, STO)
Monday, January 24, 2011 - 9:31am | 136Cabela's Inc (NYSE: CAB) was upgraded by Piper Jaffray from "neutral" to "overweight." CAB's shares closed at $21.64 on Friday. CAB's PEG ratio is 1.05. BofA/Merrill upgrade Kinetic Concepts Inc (NYSE: KCI) from "neutral" to "buy." KCI's shares closed at $44.28 on Friday. Kinetic Concepts' trailing...
-
J.P. Morgan Lowers MDT FY12 Estimate
Monday, January 24, 2011 - 9:29am | 136J.P. Morgan is lowering its FY12 estimate on Medtronic Inc. (NYSE: MDT). “Following the closing of the Ardian acquisition, we are lowering our FY12 EPS estimate another $0.03 to $3.53 (+4.4%),” J.P. Morgan writes. “This now puts us $0.13 below Street consensus ($3.66). On its own, Ardian is $0.05-....
-
Benzinga's Top Pre-Market NASDAQ Gainers (CLDA, GXDX, NVDA, ATPG)
Monday, January 24, 2011 - 9:20am | 157Clinical Data Inc (NASDAQ: CLDA) rose 43.25% to $21.53 in the pre-market session. The Food and Drug Administration (FDA) approved the CLDA's depression drug Viibryd. Genoptix Inc (NASDAQ: GXDX) added 25.81% to $24.86 in the pre-market session. Novartis AG (NYSE: NVS) announced its plans to acquire...
-
Piper Jaffray Comments On Clinical Data Inc. Following FDA Approval
Monday, January 24, 2011 - 9:04am | 232Friday evening the FDA approved Clinical Data's (NASDAQ: CLDA) NDA submission for vilazodone. Piper Jaffray believes the drug is sufficiently differentiated from existing treatments to compete in the crowded antidepression market and that its potential is underappreciated. Piper looks for Clinical...